Alzheimer's adcomm members question FDA: How can you use amyloid as the basis for an accelerated approval?
The FDA has not yet provided a persuasive scientific basis for declaring beta-amyloid as a reasonable surrogate for an accelerated approval, seven members of the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
